Goldman Sachs Downgrades Diebold (DBD) to Sell, Growth at Risk

January 9, 2013 8:05 AM EST
Get Alerts DBD Hot Sheet
Price: $25.45 -0.39%

Rating Summary:
    6 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 11
Trade DBD Now!
Join SI Premium – FREE
Goldman Sachs downgraded Diebold (NYSE: DBD) from Neutral to Sell with a price target of $27.00 (from $29.00) saying relative valuation and growth expectations appear at risk.

The firm is more cautious on (1) the company’s core ATM demand backdrop as banks focus on controlling expenses in a tough environment; (2) potential share losses in the US regional and Brazil ATM market to NCR where its order growth has shown relative strength; and (3) potential pricing risk from a shift in orders to larger banks.

Goldman lowerd 2013/2014 EPS estimates to $2.27/$2.47 from $2.41/$2.61.

For an analyst ratings summary and ratings history on Diebold click here. For more ratings news on Diebold click here.

Shares of Diebold closed at $30.77 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst EPS Change, Analyst PT Change, Downgrades, Hot Downgrades

Related Entities

Goldman Sachs

Add Your Comment